Future cohorts will prospectively measure IL-6 in these children and following outcomes such as number of infections per year, requirement for antibiotic treatment, infection-related hospitalisations, intensive care admissions related to infectious causes, sepsis, and mortality. The gene discussed is IL6; the disease is Sepsis.